Pajjiż: Ingilterra
Lingwa: Ingliż
Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)
Midazolam hydrochloride
hameln pharma Ltd
N05CD08
Midazolam hydrochloride
2mg/1ml
Solution for infusion
Intravenous; Rectal; Intramuscular
Schedule 3 (CD No Register Exempt Safe Custody)
Valid as a prescribable product
BNF: 15010401; GTIN: 5016386005510
Midazolam WHAT IS IN THIS LEAFLET 1. What Midazolam is and what it is used for 2. What you need to know before you use Midazolam 3. How to use Midazolam 4. Possible side effects 5. How to store Midazolam 6. Contents of the pack and other information 1. WHAT MIDAZOLAM IS AND WHAT IT IS USED FOR Midazolam belongs to a group of medicines called ‘benzodiazepines’. Midazolam works quickly to make you feel sleepy or to put you to sleep. It also makes you calm and relaxes your muscles. MIDAZOLAM IS USED IN ADULTS: • as a general anaesthetic to put them to sleep or to keep them asleep. MIDAZOLAM IS ALSO USED IN ADULTS AND CHILDREN: • to make them feel calm and sleepy if they are in intensive care. This is called ‘sedation’. • before and during a medical test or procedure where they are going to stay awake. It makes them feel calm and sleepy. This is called ‘conscious sedation’. • to make them feel calm and sleepy before they are given an anaesthetic. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE MIDAZOLAM DO NOT USE MIDAZOLAM: • if you are allergic (hypersensitive) to midazolam or any of the other ingredients of this medicine (listed in section 6). • if you are allergic to other benzodiazepine medicines, such as diazepam or nitrazepam. • if you have severe breathing problems and you are going to have Midazolam for ‘conscious sedation’. You must not use Midazolam if any of the above applies to you. If you are not sure, talk to your doctor or nurse before you use this medicine. WARNINGS AND PRECAUTIONS Talk to your doctor or nurse before using Midazolam: • if you are over 60 years of age. • if you have a long term illness, such as breathing problems or kidney, liver or heart problems. • if you have an illness that makes you feel very weak, run down and short of energy. • if you have something called ‘myasthenia gravis’ where your muscles are weak. • if you have ever had alcohol problems. • if you have ever had drug problems. If any of the above applies to you (or you are not sure), t Aqra d-dokument sħiħ
OBJECT 1 MIDAZOLAM 2MG/ML, SOLUTION FOR INJECTION Summary of Product Characteristics Updated 17-Nov-2014 | hameln pharmaceuticals ltd 1. Name of the medicinal product Midazolam 2 mg/ml, solution for injection 2. Qualitative and quantitative composition 1 ml Midazolam 2 mg/ml contains: Midazolam hydrochloride 2.22 mg equivalent to 2 mg Midazolam. Each 5 ml, 25 ml and 50 ml ampoule/vial contains 10 mg, 50, 100 mg Midazolam. Excipient with known effect: Midazolam 2 mg/ml contains 3.39 mg sodium per ml. This should be taken into consideration for patients on a controlled sodium diet. For the full list of excipients, see section 6.1 3. Pharmaceutical form Solution for injection/infusion or rectal solution The medicinal product is a clear and colourless solution. pH 2.9 3.7 Osmolality 275 305 mOsmol/kg 4. Clinical particulars 4.1 Therapeutic indications Midazolam 2 mg/ml is a short-acting sleep-inducing drug that is indicated: In adults • CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia • ANAESTHESIA - Premedication before induction of anaesthesia - Induction of anaesthesia: - As a sedative component in combined anaesthesia. • SEDATION IN INTENSIVE CARE UNITS In children • CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia • ANAESTHESIA - Premedication before induction of anaesthesia • SEDATION IN INTENSIVE CARE UNITS 4.2 Posology and method of administration Posology STANDARD DOSAGE Midazolam is a potent sedative agent that requires titration and slow administration. Titration is strongly recommended to safely obtain the desired level of sedation according to the clinical need, physical status, age and concomitant medication. In adults over 60 years, debilitated or chronically ill patients and paediatric patients, dose should be determined with caution and risk factors related to each patient should be taken into ac count. Standard dosages are provided in the table below. Additional det Aqra d-dokument sħiħ